Iambic Therapeutics Prices IPO at $16.00 per Share

Key Facts

1Iambic Therapeutics priced its initial public offering at $16.00 per share.

2The company's shares will be listed and traded on the Nasdaq stock exchange.

Iambic Therapeutics priced its initial public offering at $16.00 per share. Investing.com reported that the company's shares will be listed and traded on the Nasdaq stock exchange, marking the final step before official public trading begins.

The pricing follows a period of increased IPO activity within the biotechnology sector. This execution step reflects the company's transition to a public listing on the Nasdaq exchange as part of its scheduled corporate growth.